March 01, 2015 12:19 PM ET

Biotechnology

Company Overview of NPS Pharmaceuticals, Inc.

Executive Profile

Peter G. Tombros M.S., M.B.A

Former Chief Executive Officer and Director, Enzon Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships
71--

Background

Mr. Peter G. Tombros, M.S., M.B.A, has been a Professor and Distinguished Executive in Residence at the Eberly College of Science BS and MBA program at the Pennsylvania State University, an accelerated honors program designed to train scientists to become business leaders since 2005. Mr. Tombros served as Chairman and Chief Executive Officer of VivoQuest from 2002 to 2005. Mr. Tombros served as President and Chief Executive Officer of Enzon Inc. (alternate name Enzon ...

Corporate Headquarters

550 Hills Drive
Bedminster, New Jersey 07921

United States

Phone: 908-450-5300
Fax: 908-450-5351

Board Members Memberships

Former Chief Executive Officer and Director
Director
1994-2008
Former Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Audit Committee
1998-2015
Former Chairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2002-Present
Director, Chairman of Audit Committee and Member of Governance Committee
2004-Present
Director and Member of Compensation Committee
2005-Present
Director and Member of Corporate Governance & Nominating Committee
2005-2009
Former Director
2006-2009
Former Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Strategic Alternatives Committee

Education

MS 1966
Pennsylvania State University
BS 1964
Pennsylvania State University
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
$276.9K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
William John Edward Burt DPhilChief Executive Officer and Executive Director
Abzena plc
--
Kleanthis G. Xanthopoulos Ph.D.Chief Executive Officer, President, Principal Financial & Accounting Officer and Director
Regulus Therapeutics Inc.
$600.0K
Compensation as of Fiscal Year 2012.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NPS Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.